Emerging Approaches to Improving Adoptive Cell Therapy

December 7, 2021

Emerging Approaches to Improving Adoptive Cell Therapy

This mini-symposium brought together investigators taking innovative approaches to address these challenges. The expert research presented will span diverse aspects of CAR cell therapeutic development, from expanding our understanding of immune cell function to improving CAR T manufacturing to monitoring CAR cells in clinical research trials.

A moderated panel discussion allowed the audience members to interact with the speakers for Q&A.

Watch the on demand recording by following the link below.

Mini-symposium on demand


Flyer on mass cytometry for CAR cell analysis: A Streamlined Research Assay for Longitudinal Immune Monitoring of Cellular Therapies
Read now

Topics and Speakers  

» Expanding CAR T cell profiling to accelerate therapeutic insights

Greg Hopkins, PhD

Greg Hopkins
Associate Manager, Scientist, 2seventy bio



» Understanding the metabolic dynamics of T cells and CAR T cells from single-cell data

Matthew Spitzer, PhD

Matthew Spitzer, PhD
Assistant Professor, University of California San Francisco (UCSF)


» Introducing CyTOF® XT and Maxpar™ Direct™ Assays for efficient high-content immune profiling

Emily Thrash, PhD

Emily Thrash, PhD
Field Application Specialist Proteomics, Fluidigm


» Mass cytometry: A robust platform for the comprehensive immunomonitoring of CAR T cell therapies

Damien Roos-Weil, MD

Jonathan Caron, PhD 
Researcher, Assistance Publique – Hôpitaux de Paris


» Interrogating CAR T cell spatiotemporal plasticity 

Damien Roos-Weil, MD

Lior Goldberg, MD
Pediatric Oncologist, Physician-Scientist, City of Hope Comprehensive Cancer Center 




Unless explicitly and expressly stated otherwise, all products are provided for Research Use Only, not for use in diagnostic procedures. Find more information here.